Cargando…

The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome

In reproductive medicine little progress has been achieved regarding the clinical management of patients with a reduced ovarian reserve or poor ovarian response (POR) to stimulation with exogenous gonadotropins -a frustrating experience for clinicians as well as patients. Despite the efforts to opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Humaidan, Peter, Alviggi, Carlo, Fischer, Robert, Esteves, Sandro C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302217/
https://www.ncbi.nlm.nih.gov/pubmed/28232864
http://dx.doi.org/10.12688/f1000research.10382.1
_version_ 1782506495221432320
author Humaidan, Peter
Alviggi, Carlo
Fischer, Robert
Esteves, Sandro C.
author_facet Humaidan, Peter
Alviggi, Carlo
Fischer, Robert
Esteves, Sandro C.
author_sort Humaidan, Peter
collection PubMed
description In reproductive medicine little progress has been achieved regarding the clinical management of patients with a reduced ovarian reserve or poor ovarian response (POR) to stimulation with exogenous gonadotropins -a frustrating experience for clinicians as well as patients. Despite the efforts to optimize the definition of this subgroup of patients, the existing POR criteria unfortunately comprise a heterogeneous population and, importantly, do not offer any recommendations for clinical handling. Recently, the POSEIDON group ( Patient- Oriented Strategies Encompassing Individualize D Oocyte Number) proposed a new stratification of assisted reproductive technology (ART) in patients with a reduced ovarian reserve or unexpected inappropriate ovarian response to exogenous gonadotropins. In brief, four subgroups have been suggested based on quantitative and qualitative parameters, namely, i. Age and the expected aneuploidy rate; ii. Ovarian biomarkers (i.e. antral follicle count [AFC] and anti-Müllerian hormone [AMH]), and iii. Ovarian response - provided a previous stimulation cycle was performed. The new classification introduces a more nuanced picture of the “low prognosis patient” in ART, using clinically relevant criteria to guide the physician to most optimally manage this group of patients. The POSEIDON group also introduced a new measure for successful ART treatment, namely, the ability to retrieve the number of oocytes needed for the specific patient to obtain at least one euploid embryo for transfer. This feature represents a pragmatic endpoint to clinicians and enables the development of prediction models aiming to reduce the time-to-pregnancy (TTP). Consequently, the POSEIDON stratification should not be applied for retrospective analyses having live birth rate (LBR) as endpoint. Such an approach would fail as the attribution of patients to each Poseidon group is related to specific requirements and could only be made prospectively. On the other hand, any prospective approach (i.e. RCT) should be performed separately in each specific group.
format Online
Article
Text
id pubmed-5302217
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-53022172017-02-22 The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome Humaidan, Peter Alviggi, Carlo Fischer, Robert Esteves, Sandro C. F1000Res Opinion Article In reproductive medicine little progress has been achieved regarding the clinical management of patients with a reduced ovarian reserve or poor ovarian response (POR) to stimulation with exogenous gonadotropins -a frustrating experience for clinicians as well as patients. Despite the efforts to optimize the definition of this subgroup of patients, the existing POR criteria unfortunately comprise a heterogeneous population and, importantly, do not offer any recommendations for clinical handling. Recently, the POSEIDON group ( Patient- Oriented Strategies Encompassing Individualize D Oocyte Number) proposed a new stratification of assisted reproductive technology (ART) in patients with a reduced ovarian reserve or unexpected inappropriate ovarian response to exogenous gonadotropins. In brief, four subgroups have been suggested based on quantitative and qualitative parameters, namely, i. Age and the expected aneuploidy rate; ii. Ovarian biomarkers (i.e. antral follicle count [AFC] and anti-Müllerian hormone [AMH]), and iii. Ovarian response - provided a previous stimulation cycle was performed. The new classification introduces a more nuanced picture of the “low prognosis patient” in ART, using clinically relevant criteria to guide the physician to most optimally manage this group of patients. The POSEIDON group also introduced a new measure for successful ART treatment, namely, the ability to retrieve the number of oocytes needed for the specific patient to obtain at least one euploid embryo for transfer. This feature represents a pragmatic endpoint to clinicians and enables the development of prediction models aiming to reduce the time-to-pregnancy (TTP). Consequently, the POSEIDON stratification should not be applied for retrospective analyses having live birth rate (LBR) as endpoint. Such an approach would fail as the attribution of patients to each Poseidon group is related to specific requirements and could only be made prospectively. On the other hand, any prospective approach (i.e. RCT) should be performed separately in each specific group. F1000Research 2016-12-23 /pmc/articles/PMC5302217/ /pubmed/28232864 http://dx.doi.org/10.12688/f1000research.10382.1 Text en Copyright: © 2016 Humaidan P et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Opinion Article
Humaidan, Peter
Alviggi, Carlo
Fischer, Robert
Esteves, Sandro C.
The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome
title The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome
title_full The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome
title_fullStr The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome
title_full_unstemmed The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome
title_short The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome
title_sort novel poseidon stratification of ‘low prognosis patients in assisted reproductive technology’ and its proposed marker of successful outcome
topic Opinion Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302217/
https://www.ncbi.nlm.nih.gov/pubmed/28232864
http://dx.doi.org/10.12688/f1000research.10382.1
work_keys_str_mv AT humaidanpeter thenovelposeidonstratificationoflowprognosispatientsinassistedreproductivetechnologyanditsproposedmarkerofsuccessfuloutcome
AT alviggicarlo thenovelposeidonstratificationoflowprognosispatientsinassistedreproductivetechnologyanditsproposedmarkerofsuccessfuloutcome
AT fischerrobert thenovelposeidonstratificationoflowprognosispatientsinassistedreproductivetechnologyanditsproposedmarkerofsuccessfuloutcome
AT estevessandroc thenovelposeidonstratificationoflowprognosispatientsinassistedreproductivetechnologyanditsproposedmarkerofsuccessfuloutcome
AT humaidanpeter novelposeidonstratificationoflowprognosispatientsinassistedreproductivetechnologyanditsproposedmarkerofsuccessfuloutcome
AT alviggicarlo novelposeidonstratificationoflowprognosispatientsinassistedreproductivetechnologyanditsproposedmarkerofsuccessfuloutcome
AT fischerrobert novelposeidonstratificationoflowprognosispatientsinassistedreproductivetechnologyanditsproposedmarkerofsuccessfuloutcome
AT estevessandroc novelposeidonstratificationoflowprognosispatientsinassistedreproductivetechnologyanditsproposedmarkerofsuccessfuloutcome